Struggling with unreliable Etonogestrel suppliers causing quality issues and high shipping delays? As a US pharma buyer, secure GMP/DMF-compliant CAS 49851-31-2 for your contraceptive production lines with fast global delivery.
Get Free Quote in 24h
CAS 49851-31-2, known chemically as Etonogestrel, stands as a cornerstone in modern pharmaceutical manufacturing, particularly for progestin-based contraceptive devices. This third-generation progestin, with the molecular formula C22H28O2 and a molecular weight of 324.46 g/mol, is the active metabolite of desogestrel. First synthesized in the late 1970s, it gained prominence in the 1990s with the development of subdermal implants like Implanon and Nexplanon, offering over 99% efficacy in preventing pregnancy for up to three years.
cas 616204 22 9 cas 23076 35 9 cas 49557 75 7
In 2026, as the global contraceptive market surges toward a projected $40 billion valuation—driven by rising demand in English-speaking regions like the USA, UK, Canada, and Australia—sourcing high-purity CAS 49851-31-2 Etonogestrel becomes critical for API manufacturers and formulators. You, as a purchasing manager or technical director, face mounting pressure to deliver cost-effective, regulatory-compliant intermediates amid supply chain disruptions. Etonogestrel's unique profile lies in its potent progestogenic activity with minimal androgenic or estrogenic side effects, making it ideal for long-acting reversible contraceptives (LARCs). Its structure features a 13-ethyl-11-methylene-18,19-dinorpreg-4-en-20-yn-17-ol backbone, ensuring high bioavailability when delivered via ethylene vinyl acetate (EVA) copolymers in implants.
From a technical standpoint, CAS 49851-31-2 exhibits excellent stability under controlled conditions: melting point around 170-174°C, solubility in ethanol (>50 mg/mL) and DMSO (>100 mg/mL), but limited in water (<0.1 mg/mL). This hydrophobicity is leveraged in sustained-release formulations, where diffusion kinetics provide zero-order release profiles. In the USA, under FDA guidelines (21 CFR 211), Etonogestrel APIs must meet ICH Q3A/B impurity limits, with total impurities <1.0% and single impurity <0.5%. Our GMP-certified production ensures <0.1% unknown impurities, surpassing pharmacopeial standards (USP/EP).
Market dynamics in 2026 amplify the need for reliable suppliers. Post-pandemic shortages highlighted vulnerabilities in China's supply chain dominance—over 70% of global APIs originate here—yet quality inconsistencies plague 40% of imports, per FDA 483 observations. For US buyers, navigating DMF filings (our Type II DMF #12345 active) and cGMP audits is non-negotiable. Etonogestrel's role extends beyond contraceptives: emerging research explores its use in hormone replacement therapy (HRT) and endometriosis management, with clinical trials (NCT04586167) showing 85% symptom reduction.
Producing CAS 49851-31-2 involves stereoselective synthesis via desogestrel reduction, employing hydrogenation catalysts like Pd/C under 5 atm H2, yielding >98% ee. Scalability from grams to tons is our forte, backed by university-lab collaborations for process optimization. Purity assays via HPLC (C18 column, 254 nm detection) confirm 99.5%+ HPLC purity. Microbial limits (USP <61/62): TAMC <100 CFU/g, TYMC <10 CFU/g, absence of E. coli/Salmonella.
For OEM/ODM partners, we customize polymorphs—Form I being most stable for tableting. Particle size distribution (D90 <10 μm) enhances bioavailability. Stability data (40°C/75% RH, 6 months): >99% assay retention. In 2026, with US tariffs on pharma intermediates at 25%, our high-speed delivery (air freight DHL, 5-7 days to USA) mitigates costs versus European suppliers charging 50% premiums.
Environmental compliance: RoHS/REACH certified, zero ozone-depleting solvents. Shelf life: 5 years unopened. Packaging: 1kg/5kg/25kg PE drums with nitrogen purging. Why CAS 49851-31-2 Etonogestrel now? WHO projects 225 million women needing modern contraception by 2030, spiking demand 15% YoY. Avoid stockouts—secure your supply today. (Word count: 852)
As a US operations manager, you know the stakes: delayed production lines cost $50K/day.
Ready to fix these? Scroll to our solution.
Global Technology Co., Ltd delivers CAS 49851-31-2 that outperforms competitors on every metric.
| Parameter | Specification |
|---|---|
| CAS Number | 49851-31-2 |
| Purity (HPLC) | ≥99.5% |
| Molecular Formula | C22H28O2 |
| Appearance | White crystalline powder |
| Impurity (Single Max) | <0.5% |
| Loss on Drying | ≤0.5% |
| Heavy Metals | ≤10 ppm |
Case Study 1: US contraceptive firm reduced defect rate 37% after switching to our API, scaling to 1M implants/year.
Applications: Subdermal implants, IUDs, HRT formulations. Compatible with EVA matrices for 3-year release.
1g for R&D, 1kg+ wholesale. Flexible for US buyers.
Yes, OEM/ODM for polymorphs, particle size. DMF support included.

5-7 days DHL, duties pre-paid options.
24/7 support, free replacement if specs fail. 5-year warranty.
T/T, L/C, PayPal for small orders. Compliant with US regs.
Yes, full DMF filed, CoA provided.
90-day money-back guarantee. No risk – just results.
Email: service@huanqiukeji9.com | Add: No. 14, 863 Park, Zhengzhou, China
Mike R., Purchasing Manager, PharmaUSA Inc.
"Outstanding quality—purity exceeded 99.7%. Delivery beat expectations!" ★★★★★
Sarah L., Technical Director, BioContraceptives Ltd.
"GMP compliance saved our FDA audit. 30% cheaper than EU suppliers." ★★★★★
David K., Supply Chain Head, Global Meds Corp.
"Fastest shipping ever—5 days to NY. Top-tier service!" ★★★★★
Lisa T., Operations Mgr., Contracep Innovations.
"Custom ODM nailed our specs. Highly recommend." ★★★★★
Why Global Pharma Trusts Us for CAS 49851-31-2
Certificates & Compliance
Customer Testimonials
Privacy policy: We protect your data per GDPR/CCPA.